People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Park, Jong Ryul
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (1/1 displayed)
Places of action
Organizations | Location | People |
---|
article
Thermoresponsive Polymer-Antibiotic Conjugates Based on Gradient Copolymers of 2-Oxazoline and 2-Oxazine
Abstract
<p class="articleBody_abstractText">A polymer–antibiotic conjugate withthermoresponsive properties near body temperature is presented. Thebackbone polymer is a copolymer of 2-<i>n</i>-propyl-2-oxazine (PropOzi) and methoxycarbonylethyl-2-oxazoline (C<sub>2</sub>MestOx) which is conjugated with the broad-spectrum antibiotic, cefazolin, via modification of the methyl ester group of C<sub>2</sub>MestOx.The resulting polymer–antibiotic conjugate has a cloud pointtemperature near body temperature, meaning that it can form a homogenoussolution if cooled, but when injected into a skin-mimic at 37 °C, itforms a drug depot precipitate. Cleavage of the ester linker leads toquantitative release of the pristine cefazolin (with some antibioticdegradation observed) and redissolution of the polymer. When <i>Escherichia coli</i>were treated with polymer–antibiotic conjugate total clearance isobserved within 12 h. The power of this approach is the potential forlocalized antibiotic delivery, for example, at a specific tissue site orinto infected phagocytic cells.</p>